EMERGING INSIGHTS ON THE ASSOCIATION OF TUMOR MOLECULAR PHENOTYPE WITH CLINICAL BENEFIT IN METASTATIC COLORECTAL CANCER (MCRC) SUBJECTS TREATED WITH AB928+MODIFIED FOLFOX-6 (MFOLFOX-6)-MedSci.cn

EMERGING INSIGHTS ON THE ASSOCIATION OF TUMOR MOLECULAR PHENOTYPE WITH CLINICAL BENEFIT IN METASTATIC COLORECTAL CANCER (MCRC) SUBJECTS TREATED WITH AB928+MODIFIED FOLFOX-6 (MFOLFOX-6)

Udyavar, A; Cecchini, M; DiRenzo, D; Cho, S; Seitz, L; Zhang, K; Young, S; Anderson, A; Gerrick, K; Walters, M; Gilbert, H; Gardner, O; Quah, C; Jaen, J; Grossman, W

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020; 8 (): A206

科室
- - 订阅+
  - 更多科室
工具
服务

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

EMERGING INSIGHTS ON THE ASSOCIATION OF TUMOR MOLECULAR PHENOTYPE WITH CLINICAL BENEFIT IN METASTATIC COLORECTAL CANCER (MCRC) SUBJECTS TREATED WITH AB928+MODIFIED FOLFOX-6 (MFOLFOX-6)

科室

工具

服务